ArticleBreast cancer research and treatment2017

MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer.

Jinil Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.